Wimmer N - Search Results

1

Anti-proliferative effects of novel glyco-lipid-arsenicals (III) on MCF-7 human breast cancer cells.

Wimmer N, Robinson JA, Gopisetty-Venkata N, Roberts-Thomson SJ, Monteith GR, Toth I. Wimmer N, et al. Med Chem. 2006 Jan;2(1):79-87. doi: 10.2174/157340606775197714. Med Chem. 2006. PMID: 16787358

2

Syntheses of polycationic dendrimers on lipophilic peptide core for complexation and transport of oligonucleotides.

Wimmer N, Marano RJ, Kearns PS, Rakoczy EP, Toth I. Wimmer N, et al. Bioorg Med Chem Lett. 2002 Sep 16;12(18):2635-7. doi: 10.1016/s0960-894x(02)00511-5. Bioorg Med Chem Lett. 2002. PMID: 12182876

3

Inhibition of in vitro VEGF expression and choroidal neovascularization by synthetic dendrimer peptide mediated delivery of a sense oligonucleotide.

Marano RJ, Wimmer N, Kearns PS, Thomas BG, Toth I, Brankov M, Rakoczy PE. Marano RJ, et al. Among authors: wimmer n. Exp Eye Res. 2004 Oct;79(4):525-35. doi: 10.1016/j.exer.2004.06.023. Exp Eye Res. 2004. PMID: 15381036

4

Functional implications of modifying RyR-activating peptides for membrane permeability.

Dulhunty AF, Cengia L, Young J, Pace SM, Harvey PJ, Lamb GD, Chan YN, Wimmer N, Toth I, Casarotto MG. Dulhunty AF, et al. Among authors: wimmer n. Br J Pharmacol. 2005 Mar;144(6):743-54. doi: 10.1038/sj.bjp.0705981. Br J Pharmacol. 2005. PMID: 15778698 Free PMC article.

5

Dendrimer delivery of an anti-VEGF oligonucleotide into the eye: a long-term study into inhibition of laser-induced CNV, distribution, uptake and toxicity.

Marano RJ, Toth I, Wimmer N, Brankov M, Rakoczy PE. Marano RJ, et al. Among authors: wimmer n. Gene Ther. 2005 Nov;12(21):1544-50. doi: 10.1038/sj.gt.3302579. Gene Ther. 2005. PMID: 16034458

6

Novel cationic lipophilic peptides for oligodeoxynucleotide delivery.

Chan E, Amon M, Marano RJ, Wimmer N, Kearns PS, Manolios N, Rakoczy PE, Toth I. Chan E, et al. Among authors: wimmer n. Bioorg Med Chem. 2007 Jun 15;15(12):4091-7. doi: 10.1016/j.bmc.2007.03.078. Epub 2007 Mar 30. Bioorg Med Chem. 2007. PMID: 17420133

7

Synthesis and immunological evaluation of self-adjuvanting glycolipopeptide vaccine candidates.

Fujita Y, Abdel-Aal AB, Wimmer N, Batzloff MR, Good MF, Toth I. Fujita Y, et al. Among authors: wimmer n. Bioorg Med Chem. 2008 Oct 1;16(19):8907-13. doi: 10.1016/j.bmc.2008.08.064. Epub 2008 Aug 29. Bioorg Med Chem. 2008. PMID: 18789866

8

Synthesis of glycolipopeptidic building blocks for carbohydrate receptor discovery.

Ziora ZM, Wimmer N, New R, Skwarczynski M, Toth I. Ziora ZM, et al. Among authors: wimmer n. Carbohydr Res. 2011 Sep 6;346(12):1439-44. doi: 10.1016/j.carres.2011.03.019. Epub 2011 Mar 15. Carbohydr Res. 2011. PMID: 21641587

9

Biological diversity from a structurally diverse library: systematically scanning conformational space using a pyranose scaffold.

Abbenante G, Becker B, Blanc S, Clark C, Condie G, Fraser G, Grathwohl M, Halliday J, Henderson S, Lam A, Liu L, Mann M, Muldoon C, Pearson A, Premraj R, Ramsdale T, Rossetti T, Schafer K, Le Thanh G, Tometzki G, Vari F, Verquin G, Waanders J, West M, Wimmer N, Yau A, Zuegg J, Meutermans W. Abbenante G, et al. Among authors: wimmer n. J Med Chem. 2010 Aug 12;53(15):5576-86. doi: 10.1021/jm1002777. J Med Chem. 2010. PMID: 20684600

10

Discovery of PG545: a highly potent and simultaneous inhibitor of angiogenesis, tumor growth, and metastasis.

Ferro V, Liu L, Johnstone KD, Wimmer N, Karoli T, Handley P, Rowley J, Dredge K, Li CP, Hammond E, Davis K, Sarimaa L, Harenberg J, Bytheway I. Ferro V, et al. Among authors: wimmer n. J Med Chem. 2012 Apr 26;55(8):3804-13. doi: 10.1021/jm201708h. Epub 2012 Apr 13. J Med Chem. 2012. PMID: 22458531

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters